Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET Imaging in Malignancy
NCT04023240Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Jul 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-FAPI in cancer, sponsored by Stanford University. Planned start Jul 2023; status: withdrawn.
02
Drugs
68Ga-FAPI
03
Conditions
cancer
Beyond the preview
Go deeper on NCT04023240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023240.